Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Study of MAX-40279 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT04187495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60
ClinicalTrials.gov study NCT04083911. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML
ClinicalTrials.gov study NCT05503355. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML
ClinicalTrials.gov study NCT03081780. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04443751. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated
ClinicalTrials.gov study NCT04716114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NK Cell Therapy Recurrent/Refractory Elderly AML
ClinicalTrials.gov study NCT04599452. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ClinicalTrials.gov study NCT06317649. IPD Sharing: YES. Countries: 2. Publications: 0.
Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01001143. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05000801. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
ClinicalTrials.gov study NCT06158828. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1
ClinicalTrials.gov study NCT07155382. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
ClinicalTrials.gov study NCT02756962. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML
ClinicalTrials.gov study NCT03417427. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS
ClinicalTrials.gov study NCT02732184. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Effects of AMPC in the Treatments of Refractory or Relapsed AML
ClinicalTrials.gov study NCT03825146. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
ClinicalTrials.gov study NCT06533761. IPD Sharing: NO. Countries: 2. Publications: 0.
CAV Regimen for R/R AML
ClinicalTrials.gov study NCT05657639. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS
ClinicalTrials.gov study NCT02204020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS
ClinicalTrials.gov study NCT03187288. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.